Latest News

Date Title Topic
27 Jun 2013 Confronting the Complexity of EGFR/HER Targeted Therapies in Breast, Colorectal and Lung Cancers Personalised medicine
26 Jun 2013 A Comprehensive Genomic Mutation Profiling Analysis of Adenoid Cystic Carcinoma Pathology/Molecular biology - Translational research - Head and neck cancers
25 Jun 2013 Identifying the Drivers of Breast Cancer Breast cancer - Translational research
24 Jun 2013 A Novel Agent, Ibrutinib, Shows Potential as a Safe, Effective, Targeted Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
18 Jun 2013 EMUC 2013 Press Release: From Guidelines to Personalised Medicine 5th EMUC Examines Personalised Therapies for Urological Cancers Genitourinary cancers
Locum Consultant, Medical Oncology, UK
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine - Translational research
13 Jun 2013 First-line Treatment Strategies for Advanced-Stage Follicular Lymphoma: Which is The Best One? Haematologic malignancies
Melanoma
06 Jun 2013 European Medicines Agency recommends granting a marketing authorisation for lipegfilgrastim Palliative and supportive care - Anticancer agents & Biologic therapy
05 Jun 2013 Bevacizumab: The First Agent to Remarkably Improve Survival in Recurrent Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
04 Jun 2013 European Medicines Agency recommends approval of pomalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jun 2013 FDA Approves Trametinib and Dabrafenib for Unresectable or Metastatic BRAF-Mutated Melanoma Melanoma - Anticancer agents & Biologic therapy
17 May 2013 Cisplatin-Based Chemoradiation: In Which Setting(s) Could Cisplatin Replace Mitomycin in the Treatment of Localised Anal Squamous Cell Carcinoma? Gastrointestinal cancers